Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/16/25 16:42 | 12/12/25 | ELAN | Health | Drug | Pharmaceutical Preparations | Kurzius Lawrence Erik | IN | D | 1 | P | 213 | 21.30 | 0 | 10 | 8 | 132 | D | |||||||||||||||
12/15/25 16:43 | 12/11/25 | ELAN | Health | Drug | Pharmaceutical Preparations | Modi Rajeev A. | IN | O | SEE REMA | 1 | P | 96 | 21.33 | 0 | 5 | 4 | 123 | D | ||||||||||||||
12/15/25 16:42 | 12/11/25 | ELAN | Health | Drug | Pharmaceutical Preparations | Vanhimbergen Robert M | IN | O | EVP,CFO | 1 | P | 150 | 21.64 | 0 | 7 | 6 | 124 | D | ||||||||||||||
12/15/25 16:41 | 12/11/25 | ELAN | Health | Drug | Pharmaceutical Preparations | Simmons Jeffrey N | IN | DO | P,CEO,Di | 1 | P | 478 | 21.75 | 0 | 22 | 1 | 1,969 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |